Superior Performance of SaniSure® PharmaClear® LH Tubing in Extended Fill/Finish Applications
Superior Performance of SaniSure® PharmaClear® LH Tubing in Extended Fill/Finish Applications
This whitepaper explores the critical role of silicone tubing in aseptic parenteral drug production, focusing on the fill/finish process—a vital phase where sterility is paramount. As the industry shifts toward continuous processing and the demand for biologic drugs increases, the durability of tubing used in these operations becomes essential. The document presents findings from a technical engineering study that assessed the performance of various tubing brands under operational conditions. Notably, SaniSure® PharmaClear® LH tubing significantly outperformed its competitors, providing up to 4.8 times more fills, which translates into extended fill runs, reduced costs, and minimized risks.
In addition to highlighting the superior durability of SaniSure® PharmaClear® LH tubing, the whitepaper delves into the broader context of aseptic processing, including regulatory expectations, the advantages of single-use technologies, and the importance of selecting the right materials to meet stringent demands. It emphasizes the critical need for high-performing equipment and consumables to maintain sterility and ensure product integrity throughout the manufacturing process. By choosing SaniSure® Pharm-A-Clear LH® tubing, drug manufacturers can achieve longer operational runs with fewer interruptions, ensuring both efficiency and compliance with health regulations.
